Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies
- DOI
- 10.1016/j.autrev.2014.10.019
- Published
- 2015-03
- Container
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.autrev.2014.10.019,
title = {Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies},
author = {Laurent Arnaud and Alexis Mathian and Hervé Devilliers and Amelia Ruffatti and Maria Tektonidou and Ricardo Forastiero and Vittorio Pengo and Marc Lambert and Guillaume Lefevre and Maria Angeles Martinez-Zamora and Juan Balasch and Denis Wahl and Zahir Amoura},
year = {2015},
journal = {Autoimmunity Reviews},
doi = {10.1016/j.autrev.2014.10.019},
url = {https://doi.org/10.1016/j.autrev.2014.10.019}
}RIS
TY - JOUR TI - Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies AU - Laurent Arnaud AU - Alexis Mathian AU - Hervé Devilliers AU - Amelia Ruffatti AU - Maria Tektonidou AU - Ricardo Forastiero AU - Vittorio Pengo AU - Marc Lambert AU - Guillaume Lefevre AU - Maria Angeles Martinez-Zamora AU - Juan Balasch AU - Denis Wahl AU - Zahir Amoura PY - 2015 JO - Autoimmunity Reviews DO - 10.1016/j.autrev.2014.10.019 UR - https://doi.org/10.1016/j.autrev.2014.10.019 ER -
APA
Arnaud, L., Mathian, A., Devilliers, H., Ruffatti, A., Tektonidou, M., Forastiero, R., Pengo, V., Lambert, M., Lefevre, G., Martinez-Zamora, M. A., Balasch, J., Wahl, D., & Amoura, Z. (2015). Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2014.10.019
Source records
- crossref · retrieved 2026-11-08T06:22:44.712Z